Sign inGet started

JACOBSEN MICHAEL A

Insider CIK 1529087 · OMER VP, Finance & CAO · AVII VP of Finance and PAO

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
OMER OMEROS CORP A Award deriv2024-04-252024-04-29100,000— $0100,000SEC↗
OMER OMEROS CORP A Award deriv2023-09-222023-09-27100,000— $0100,000SEC↗
OMER OMEROS CORP A Award deriv2022-09-212022-09-2385,000— $085,000SEC↗
OMER OMEROS CORP A Award deriv2021-07-022021-07-0675,000— $075,000SEC↗
OMER OMEROS CORP M Exercise deriv2021-02-222021-02-238,100— $065,000SEC↗
OMER OMEROS CORP M Exercise2021-02-222021-02-238,100$10.27 $83.2K22,100SEC↗
OMER OMEROS CORP S Sale2021-02-222021-02-238,100$23.28 $188.6K14,000SEC↗
OMER OMEROS CORP M Exercise deriv2021-02-192021-02-2310,000— $073,100SEC↗
OMER OMEROS CORP S Sale2021-02-192021-02-2310,000$22.64 $226.4K14,000SEC↗
OMER OMEROS CORP M Exercise2021-02-192021-02-2310,000$10.27 $102.7K24,000SEC↗
OMER OMEROS CORP S Sale2021-02-102021-02-121,900$22.49 $42.7K14,000SEC↗
OMER OMEROS CORP M Exercise2021-02-102021-02-121,900$10.27 $19.5K15,900SEC↗
OMER OMEROS CORP M Exercise deriv2021-01-202021-01-2110,000$9.37 $93.7K19,188SEC↗
OMER OMEROS CORP M Exercise deriv2021-01-202021-02-121,900— $083,100SEC↗
OMER OMEROS CORP M Exercise2021-01-202021-01-2110,000$9.37 $93.7K14,000SEC↗
OMER OMEROS CORP S Sale2021-01-192021-01-219,500$19.95 $189.5K4,000SEC↗
OMER OMEROS CORP A Award deriv2020-03-012020-03-0370,000— $070,000SEC↗
OMER OMEROS CORP A Award deriv2019-02-082019-02-1265,000— $065,000SEC↗
OMER OMEROS CORP M Exercise deriv2018-05-152018-05-1612,812— $034,188SEC↗
OMER OMEROS CORP M Exercise deriv2018-05-152018-05-165,000— $029,188SEC↗
OMER OMEROS CORP M Exercise2018-05-152018-05-1612,812$9.37 $120.0K21,312SEC↗
OMER OMEROS CORP S Sale2018-05-152018-05-1612,812$24.95 $319.7K8,500SEC↗
OMER OMEROS CORP M Exercise2018-05-152018-05-165,000$9.37 $46.8K13,500SEC↗
OMER OMEROS CORP M Exercise deriv2018-05-142018-05-1610,980— $047,000SEC↗
OMER OMEROS CORP M Exercise2018-05-142018-05-1610,980$9.37 $102.9K19,480SEC↗
OMER OMEROS CORP S Sale2018-05-142018-05-1610,980$22.45 $246.5K8,500SEC↗
OMER OMEROS CORP A Award deriv2018-04-082018-04-1060,000— $060,000SEC↗
OMER OMEROS CORP M Exercise deriv2018-01-042018-01-051,000— $057,980SEC↗
OMER OMEROS CORP M Exercise2018-01-042018-01-051,000$9.37 $9.4K8,500SEC↗
OMER OMEROS CORP M Exercise deriv2018-01-032018-01-051,020— $058,980SEC↗
OMER OMEROS CORP M Exercise2018-01-032018-01-051,020$9.37 $9.6K8,520SEC↗
OMER OMEROS CORP S Sale2018-01-032018-01-051,020$22.45 $22.9K7,500SEC↗
OMER OMEROS CORP M Exercise deriv2017-06-162017-06-1614,000— $060,000SEC↗
OMER OMEROS CORP M Exercise2017-06-162017-06-1614,000$9.37 $131.2K19,500SEC↗
OMER OMEROS CORP S Sale2017-06-162017-06-1612,000$24.95 $299.4K7,500SEC↗
OMER OMEROS CORP M Exercise deriv2017-06-152017-06-1514,000— $074,000SEC↗
OMER OMEROS CORP S Sale2017-06-152017-06-1512,000$22.45 $269.4K5,500SEC↗
OMER OMEROS CORP M Exercise2017-06-152017-06-1514,000$9.37 $131.2K17,500SEC↗
OMER OMEROS CORP M Exercise deriv2017-06-142017-06-1512,850— $088,000SEC↗
OMER OMEROS CORP M Exercise2017-06-142017-06-1512,850$9.37 $120.4K12,850SEC↗
OMER OMEROS CORP S Sale2017-06-142017-06-159,350$19.95 $186.5K3,500SEC↗
OMER OMEROS CORP M Exercise deriv2017-06-132017-06-152,650— $0100,850SEC↗
OMER OMEROS CORP S Sale2017-06-132017-06-152,650$19.95 $52.9K0SEC↗
OMER OMEROS CORP M Exercise2017-06-132017-06-152,650$9.37 $24.8K2,650SEC↗
OMER OMEROS CORP A Award deriv2017-02-262017-02-2870,000— $070,000SEC↗
OMER OMEROS CORP A Award deriv2016-12-052016-12-0785,000— $085,000SEC↗
OMER OMEROS CORP A Award deriv2016-02-192016-02-1985,000— $085,000SEC↗
OMER OMEROS CORP A Award deriv2014-10-292014-10-31100,000— $0100,000SEC↗
SRPT Sarepta Therapeutics, Inc. A Award deriv2012-08-232012-08-2748,500— $048,500SEC↗
SRPT Sarepta Therapeutics, Inc. A Award2012-08-232012-08-277,500— $07,500SEC↗
AVII AVI BIOPHARMA INC A Award deriv2012-04-242012-04-2522,211— $022,211SEC↗